A preprint of the results were released last month, which revealed that all three vaccine formulations in the trial resulted in 'robust immune responses'.
Both Bharat Biotech and SII released factsheets indicating which categories of people should be exempted from the list of beneficiaries. See the full list here.
Out of the 45 lakh doses, over 8 lakh will be supplied to friendly countries such as Mauritius, Philippines and Myanmar, free of cost as a goodwill gesture.
Doctors in Assam, Maharashtra, Haryana say there’s no reason to not take Covaxin. But some AIIMS doctors in Delhi say they want to wait for the safety and efficacy data.
In the consent form, the Covaxin manufacturer said the compensation will be paid in case if the serious adverse effect is proven to be causally related to the vaccine.
Analysts say supply to government amid low distribution, marketing and R&D costs could aid profits. Bharat Biotech vaccine is priced at Rs 206 per dose while SII’s is at Rs 200.
Govt firm will buy vaccines from Serum Institute of India & Bharat Biotech and supply them to Nepal, Bangladesh, Sri Lanka, Afghanistan, Seychelles and Mauritius.
People's University of Bhopal, the trial site, denies the claim that participants have been kept in the dark about the nature of the exercise, and say all checks and balances are in place.
Countering insurgency needs the Pakistan Army to demonstrate a political will that ties leaders at the centre with those in the borderlands. But it may not have the imagination.
Centre for Science and Environment in new report makes case for rationalising GST on waste material, saying most informal operators can’t afford high tax & it also hinders recycling.
21st edition of annual joint military exercise will be held from 1 to 16 September, aimed at sharing military tech, operational best practices & disaster relief coordination methods.
Standing up to America is usually not a personal risk for a leader in India. Any suggestions of foreign pressure unites India behind who they see as leading them in that fight.
COMMENTS